The prognosis of glioma patients varies significantly and is influenced by factors such as tumor grade, isocitrate dehydrogenase (IDH) mutation (8), and epidermal growth factor receptor (EGFR) amplification (9). Here, EGFR is linked to central nervous system cancer.